Fair call HT, i can understand up voting PITON72 for his research, i read all his posts and regularly thumb up his work.
My original post was a bit " tongue in cheek"
coming a day after another competitor Anavex, failed in their Rett Syndrome trial. I am sure many here had a smile on their face knowing NEU/Daybue has a stronger position in the Market as a result. Anyway we are all on the same side and hope to see further NEU success in 2024.
HNY to all.
Fair call HT, i can understand up voting PITON72 for his...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.70 |
Change
0.520(2.71%) |
Mkt cap ! $2.515B | |||
| Open | High | Low | Value | Volume |
| $19.39 | $19.84 | $19.28 | $5.675M | 288.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1531 | $19.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.81 | 557 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.70 |
Change
0.520 ( 2.59 %) |
||||
| Open | High | Low | Volume | ||
| $19.50 | $19.84 | $19.28 | 87628 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| NEU (ASX) Chart |